Description: Möglichkeiten und Grenzen der Nutzung kleiner Zyklotrone bei der Produktion medizinisch relevanter Radionuklide

This title appears in the Scientific Report : 2021

Möglichkeiten und Grenzen der Nutzung kleiner Zyklotrone bei der Produktion medizinisch relevanter Radionuklide

Radionuclides for in vivo imaging studies as well as for internal radiotherapy are produced using both nuclear reactors and cyclotrons. In this contribution we discuss the possibilities of production of different types of radionuclides using a small medical cyclotron (Ep = 18 MeV; Ed = 9 MeV). Besid...

Personal Name(s):	Neumaier, Bernd (Corresponding author)
	Spahn, Ingo / Qaim, Syed M.
Contributing Institute:	Nuklearchemie; INM-5
Published in:	Der @Nuklearmediziner, 44 (2021) 02, S. 120 - 126
Imprint:	Stuttgart Thieme 2021
DOI:	10.1055/a-1380-7815
Document Type:	Journal Article
Research Program:	Decoding Brain Organization and Dysfunction
Link:	Published on 2021-06-10. Available in OpenAccess from 2022-06-10.
	Publikationsportal JuSER

Please use the identifier: http://hdl.handle.net/2128/27955 in citations.
Please use the identifier: http://dx.doi.org/10.1055/a-1380-7815 in citations.

Radionuclides for in vivo imaging studies as well as for internal radiotherapy are produced using both nuclear reactors and cyclotrons. In this contribution we discuss the possibilities of production of different types of radionuclides using a small medical cyclotron (Ep = 18 MeV; Ed = 9 MeV). Besides routine production of short-lived “standard” positron emitters 11C, 15O and 18F, several “non-standard” positron emitters like 64Cu, 86Y, 89Zr etc. could also be produced in quantities sufficient for extended positron emission tomography. It is, however, necessary to develop a suitable target system for irradiation of enriched material. In principle, it is then also possible to produce in small amounts a few SPECT radionuclides (67Ga, 111In, 123I) as well as therapy-related radionuclides (67Cu, 103Pd, 186Re)